BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29806826)

  • 1. Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy.
    Wang WJ; Chiou JF; Huang Y
    J Vis Exp; 2018 May; (135):. PubMed ID: 29806826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites.
    Teh BS; Paulino AC; Lu HH; Chiu JK; Richardson S; Chiang S; Amato R; Butler EB; Bloch C
    Technol Cancer Res Treat; 2007 Aug; 6(4):347-54. PubMed ID: 17668943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers.
    Shimohigashi Y; Toya R; Saito T; Ikeda O; Maruyama M; Yonemura K; Nakaguchi Y; Kai Y; Yamashita Y; Oya N; Araki F
    Radiat Oncol; 2017 Mar; 12(1):61. PubMed ID: 28335794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
    Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
    BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical feasibility and clinical evaluation of 4D-MRI guided liver SBRT on the MR-linac.
    van de Lindt TN; Nowee ME; Janssen T; Schneider C; Remeijer P; van Pelt VWJ; Betgen A; Jansen EPM; Sonke JJ
    Radiother Oncol; 2022 Feb; 167():285-291. PubMed ID: 35033603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
    König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correspondence model-based 4D VMAT dose simulation for analysis of local metastasis recurrence after extracranial SBRT.
    Sothmann T; Gauer T; Wilms M; Werner R
    Phys Med Biol; 2017 Nov; 62(23):9001-9017. PubMed ID: 29059054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating respiratory-gated PET-based target volume delineation in liver SBRT planning, a pilot study.
    Riou O; Serrano B; Azria D; Paulmier B; Villeneuve R; Fenoglietto P; Artenie A; Ortholan C; Faraggi M; Thariat J
    Radiat Oncol; 2014 Jun; 9():127. PubMed ID: 24885897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verification of planning target volume settings in volumetric modulated arc therapy for stereotactic body radiation therapy by using in-treatment 4-dimensional cone beam computed tomography.
    Takahashi W; Yamashita H; Kida S; Masutani Y; Sakumi A; Ohtomo K; Nakagawa K; Haga A
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):426-31. PubMed ID: 23562767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of planned dose on different CT image sets to four-dimensional Monte Carlo dose recalculation using the patient's actual breathing trace for lung stereotactic body radiation therapy.
    Freislederer P; von Münchow A; Kamp F; Heinz C; Gerum S; Corradini S; Söhn M; Reiner M; Roeder F; Floca R; Alber M; Belka C; Parodi K
    Med Phys; 2019 Jul; 46(7):3268-3277. PubMed ID: 31074510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of respiratory motion and treatment technique on stereotactic body radiation therapy for liver cancer.
    Wu QJ; Thongphiew D; Wang Z; Chankong V; Yin FF
    Med Phys; 2008 Apr; 35(4):1440-51. PubMed ID: 18491539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulated Delivered Dose Response of Stereotactic Body Radiation Therapy for Liver Metastases.
    Swaminath A; Massey C; Brierley JD; Dinniwell R; Wong R; Kim JJ; Velec M; Brock KK; Dawson LA
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):639-48. PubMed ID: 26461006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery for gynecologic cancer.
    Kunos C; Brindle JM; Debernardo R
    J Vis Exp; 2012 Apr; (62):. PubMed ID: 22546879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4D CT image artifacts affect local control in SBRT of lung and liver metastases.
    Sentker T; Schmidt V; Ozga AK; Petersen C; Madesta F; Hofmann C; Werner R; Gauer T
    Radiother Oncol; 2020 Jul; 148():229-234. PubMed ID: 32442870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases.
    Andratschke N; Alheid H; Allgäuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Gerum S; Guckenberger M; Hildebrandt G; Klement RJ; Lewitzki V; Ostheimer C; Papachristofilou A; Petersen C; Schneider T; Semrau R; Wachter S; Habermehl D
    BMC Cancer; 2018 Mar; 18(1):283. PubMed ID: 29534687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the validity of density overrides for VMAT lung SBRT planning.
    Wiant D; Vanderstraeten C; Maurer J; Pursley J; Terrell J; Sintay BJ
    Med Phys; 2014 Aug; 41(8):081707. PubMed ID: 25086517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of normalized prescription isodose selection for stereotactic body radiation therapy: conventional vs robotic linac.
    Ding C; Solberg TD; Hrycushko B; Xing L; Heinzerling J; Timmerman RD
    Med Phys; 2013 May; 40(5):051705. PubMed ID: 23635253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.